Literature DB >> 25412399

The hidden harm behind the return of results from personal genome services: a need for rigorous and responsible evaluation.

A Cecile J W Janssens1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25412399     DOI: 10.1038/gim.2014.169

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  13 in total

1.  Effect of direct-to-consumer genomewide profiling to assess disease risk.

Authors:  Cinnamon S Bloss; Nicholas J Schork; Eric J Topol
Journal:  N Engl J Med       Date:  2011-01-12       Impact factor: 91.245

2.  Regulation: The FDA is overcautious on consumer genomics.

Authors:  Robert C Green; Nita A Farahany
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962

3.  The FDA and 23andMe: violating the First Amendment or protecting the rights of consumers?

Authors:  Linnea M Baudhuin
Journal:  Clin Chem       Date:  2014-05-01       Impact factor: 8.327

4.  Combining 33 genetic variants with prostate-specific antigen for prediction of prostate cancer: longitudinal study.

Authors:  Mattias Johansson; Benny Holmström; Sally R Hinchliffe; Anders Bergh; Ulf-Håkan Stenman; Göran Hallmans; Fredrik Wiklund; Pär Stattin
Journal:  Int J Cancer       Date:  2011-04-01       Impact factor: 7.396

5.  Disclosure of APOE genotype for risk of Alzheimer's disease.

Authors:  Robert C Green; J Scott Roberts; L Adrienne Cupples; Norman R Relkin; Peter J Whitehouse; Tamsen Brown; Susan LaRusse Eckert; Melissa Butson; A Dessa Sadovnick; Kimberly A Quaid; Clara Chen; Robert Cook-Deegan; Lindsay A Farrer
Journal:  N Engl J Med       Date:  2009-07-16       Impact factor: 91.245

6.  Patients' understanding of and responses to multiplex genetic susceptibility test results.

Authors:  Kimberly A Kaphingst; Colleen M McBride; Christopher Wade; Sharon Hensley Alford; Robert Reid; Eric Larson; Andreas D Baxevanis; Lawrence C Brody
Journal:  Genet Med       Date:  2012-07       Impact factor: 8.822

Review 7.  Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.

Authors:  Theresa M Marteau; David P French; Simon J Griffin; A T Prevost; Stephen Sutton; Clare Watkinson; Sophie Attwood; Gareth J Hollands
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

8.  Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms.

Authors:  Jose M de Miguel-Yanes; Peter Shrader; Michael J Pencina; Caroline S Fox; Alisa K Manning; Richard W Grant; Josèe Dupuis; Jose C Florez; Ralph B D'Agostino; L Adrienne Cupples; James B Meigs
Journal:  Diabetes Care       Date:  2010-10-01       Impact factor: 19.112

9.  Variations in predicted risks in personal genome testing for common complex diseases.

Authors:  Rachel R J Kalf; Raluca Mihaescu; Suman Kundu; Peter de Knijff; Robert C Green; A Cecile J W Janssens
Journal:  Genet Med       Date:  2013-06-27       Impact factor: 8.822

10.  Return of individual genetic results in a high-risk sample: enthusiasm and positive behavioral change.

Authors:  Sarah M Hartz; Emily Olfson; Robert Culverhouse; Patricia Cavazos-Rehg; Li-Shiun Chen; James DuBois; Sherri Fisher; Kimberly Kaphingst; David Kaufman; Andrew Plunk; Shelina Ramnarine; Stephanie Solomon; Nancy L Saccone; Laura J Bierut
Journal:  Genet Med       Date:  2014-08-28       Impact factor: 8.822

View more
  8 in total

1.  Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium.

Authors:  Laura M Amendola; Jill O Robinson; Ragan Hart; Sawona Biswas; Kaitlyn Lee; Barbara A Bernhardt; Kelly East; Marian J Gilmore; Tia L Kauffman; Katie L Lewis; Myra Roche; Sarah Scollon; Julia Wynn; Carrie Blout
Journal:  J Genet Couns       Date:  2018-03-01       Impact factor: 2.537

2.  Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study.

Authors:  Xin Niu; Laura M Amendola; Ragan Hart; Caroline S Bennette; Patrick Heagerty; Martha Horike-Pyne; Susan B Trinidad; Elisabeth A Rosenthal; Bryan Comstock; Chris Nefcy; Fuki M Hisama; Robin L Bennett; William M Grady; Carlos J Gallego; Peter Tarczy-Hornoch; Stephanie M Fullerton; Wylie Burke; Dean A Regier; Michael O Dorschner; Brian H Shirts; Peggy D Robertson; Deborah A Nickerson; Donald L Patrick; Gail P Jarvik; David L Veenstra
Journal:  Contemp Clin Trials       Date:  2019-08-07       Impact factor: 2.226

3.  Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.

Authors:  Kurt D Christensen; J Scott Roberts; Peter J Whitehouse; Charmaine D M Royal; Thomas O Obisesan; L Adrienne Cupples; Jacqueline A Vernarelli; Deepak L Bhatt; Erin Linnenbringer; Melissa B Butson; Grace-Ann Fasaye; Wendy R Uhlmann; Susan Hiraki; Na Wang; Robert Cook-Deegan; Robert C Green
Journal:  Ann Intern Med       Date:  2016-01-26       Impact factor: 25.391

4.  "Not pathogenic until proven otherwise": perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project.

Authors:  Elizabeth Ormondroyd; Michael P Mackley; Edward Blair; Judith Craft; Julian C Knight; Jenny C Taylor; John Taylor; Hugh Watkins
Journal:  Genet Med       Date:  2017-10-26       Impact factor: 8.822

Review 5.  Governing the research-care divide in clinical biobanking: Dutch perspectives.

Authors:  Martin Boeckhout; Conor M W Douglas
Journal:  Life Sci Soc Policy       Date:  2015-08-06

Review 6.  Incidental Findings with Genomic Testing: Implications for Genetic Counseling Practice.

Authors:  Myra I Roche; Jonathan S Berg
Journal:  Curr Genet Med Rep       Date:  2015-08-25

7.  The response to receiving phenotypic and genetic coronary heart disease risk scores and lifestyle advice - a qualitative study.

Authors:  Guy Shefer; Barbora Silarova; Juliet Usher-Smith; Simon Griffin
Journal:  BMC Public Health       Date:  2016-12-03       Impact factor: 3.295

8.  Attitudes toward genomics and precision medicine.

Authors:  James M DuBois; Jessica Mozersky; Alison Antes; Tammy English; Meredith V Parsons; Kari Baldwin
Journal:  J Clin Transl Sci       Date:  2021-04-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.